472 related articles for article (PubMed ID: 8793147)
1. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor.
Raison CL; Guze BH; Kissell RL
J Clin Psychopharmacol; 1994 Aug; 14(4):285-6. PubMed ID: 7525662
[No Abstract] [Full Text] [Related]
3. [Treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor G-CSF].
Heinz P; Müller H; Bauer M
Psychiatr Prax; 1994 Mar; 21(2):81. PubMed ID: 7515190
[No Abstract] [Full Text] [Related]
4. Clozapine-induced agranulocytosis and colony-stimulating cytokines.
Ryabik BM; Nguyen VT; Mann RM; Smith JD; Lippmann SB
Gen Hosp Psychiatry; 1993 Jul; 15(4):263-5. PubMed ID: 7688331
[TBL] [Abstract][Full Text] [Related]
5. Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
Lally J; Malik S; Whiskey E; Taylor DM; Gaughran FP; Krivoy A; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Aug; 37(4):441-446. PubMed ID: 28437295
[TBL] [Abstract][Full Text] [Related]
6. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
Kolli V; Denton K; Borra D; Pulluri M; Sharma A
Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia.
Schuld A; Kraus T; Hinze-Selch D; Haack M; Pollmächer T
Acta Psychiatr Scand; 2000 Aug; 102(2):153-5. PubMed ID: 10937789
[TBL] [Abstract][Full Text] [Related]
8. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
9. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
10. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
van de Loosdrecht AA; Faber HJ; Hordijk P; Uges DR; Smit A
Neth J Med; 1998 Jan; 52(1):26-9. PubMed ID: 9573739
[TBL] [Abstract][Full Text] [Related]
11. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
12. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS
Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
[No Abstract] [Full Text] [Related]
13. Lithium and clozapine-induced neutropenia/agranulocytosis.
Blier P; Slater S; Measham T; Koch M; Wiviott G
Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
[TBL] [Abstract][Full Text] [Related]
14. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
Rajagopal G; Graham JG; Haut FF
J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
[TBL] [Abstract][Full Text] [Related]
15. Association between clozapine-induced agranulocytosis and HLA subtyping.
Lopez-Garcia P; Teresa Rodriguez J; De Castro P; Landecho I; Zapata R
J Clin Psychiatry; 2006 Oct; 67(10):1652-3. PubMed ID: 17107265
[No Abstract] [Full Text] [Related]
16. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW
J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744
[TBL] [Abstract][Full Text] [Related]
18. G-CSF and the management of clozapine-induced agranulocytosis.
Gerson SL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
[TBL] [Abstract][Full Text] [Related]
19. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
Lau KL; Yim PH
East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
[TBL] [Abstract][Full Text] [Related]
20. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles N; Myles H; Clark SR; Bird R; Siskind D
Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
